Insider trade

Damora Therapeutics (DMRA)CEO bought ~$253K

Jennifer Jarrett, CEO at Damora Therapeutics, bought ~$253K of Damora Therapeutics shares.

~$253K
Approx. value · 13K sh @ $20.23: 513K
Holds after · shares reported

Traded: Sep 25, 2026
Filed: Sep 28, 2026

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Damora Therapeutics

For Damora Therapeutics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DMRA page.

How this filing works

Other disclosures at Damora Therapeutics

Everything OQRO holds on this company is on its DMRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data